Adenia Partners, a private equity firm investing in Africa, today announced it has completed the acquisition of Africa Biosystems Ltd., a distributor of life sciences and clinical diagnostics equipment in East Africa.

ABL is headquartered in Kenya with subsidiary offices in Uganda and Tanzania. The company’s instruments are used to conduct research and diagnosis across the animal, human and crop sectors with product applications that span molecular, cell and protein biology and DNA forensics. ABL’s customers fall into various end markets including government and non-governmental organizations, academic institutions, and the private sector.

“At a time when the life sciences market in East Africa is expected to grow significantly due to rising healthcare needs, we are excited to invest in ABL, which has built a strong reputation in the region with its exemplary service and technical know-how,” said Martha Osier, partner at Adenia. “We look forward to working together with the management team to capitalize on this growth, expand ABL’s customer base and take the business to the next level.”

Yasmin Verjee, said managing director and co-founder of Africa Biosystems, said, “We are thrilled to welcome Adenia as an investor and look forward to our next phase of growth. With their trusted guidance, we plan to deepen our commitment to developing the regional markets, while boosting awareness of our products and their applications within East Africa’s life sciences sector.”